SightfileU.S. market data from official filings

Companies › CAPR

CAPRICOR THERAPEUTICS INC (CAPR)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001133869 · EDGAR filings · Updated 2026-07-14

CAPRICOR THERAPEUTICS INC (CAPR) has reported institutional ownership of 58.8%, with 177 institutional managers holding positions valued at $1.03B per the latest 13F reporting period. SEC filings include an active substantial-doubt (going concern) disclosure per the filings.

Institutional ownership
58.8%
Institutional managers
177
Reported 13F value
$1.03B
Insider activity
2 trans.
$0 net flat
Data flags
1 active
from SEC filings

Latest updates

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, CAPRICOR THERAPEUTICS INC has 177 institutional holders and institutional ownership of 58.8%.

Insider activity

Insiders reported 2 transactions (0 buys, 0 sells) across 2 reporting insiders, with a net reported value of $0.

Data flags from SEC filings

Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2025-11-10 (recurring since 2024-03-11) — source filing. The authoritative details are those stated in the filing itself.

Related companies

NOVOCURE LTD (NVCR) · IMMATICS N.V (IMTX) · RECURSION PHARMACEUTICALS IN (RXRX) · CORVUS PHARMACEUTICALS INC (CRVS) · XENCOR INC COM (XNCR) · ARDELYX INC (ARDX)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-14.